- recruiting
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
This study aims to better understand advanced Mycosis Fungoides (MF) and Sezary Syndrome (SS), types of skin lymphoma. Researchers are collecting information from patients to identify who might be at higher or lower risk, helping doctors provide better care for these conditions.
United States · Argentina · Australia - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
This study is looking at a new medicine called ABBV-291 for adults with a type of cancer called Non-Hodgkin's Lymphoma. It's the first time this medicine is being given to people, to check if it's safe, what side effects it might cause, and how it works in the body.
Spain · Denmark · Sweden - active not recruitingPHASE3
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
This study is for people who have already been taking a medicine called venetoclax for their cancer in another trial. It allows them to keep taking venetoclax if it's helping them and they're not having bad side effects, so doctors can learn more about its long-term safety.
United States · Australia · Austria - recruiting
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
This study is gathering information on adults in the UK with acute lymphoblastic leukaemia (ALL) or similar blood cancers. Doctors want to learn more about how these cancers are diagnosed and treated, and how patients recover. It helps improve future care for people with these conditions, whether or not they're on a specific trial.
Austria · Germany - recruitingPHASE1
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
This study is looking at a new medicine called ABBV-291 for adults with a type of cancer called Non-Hodgkin's Lymphoma. It aims to check if the medicine is safe, what dose works best, and if it helps to treat the cancer that has come back or hasn’t responded to other treatments.
United States · Australia · Israel - active not recruitingPHASE1
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
This study is looking into a new tablet medicine, ABBV-525, for adults with certain B-cell cancers like lymphoma and leukaemia. It aims to check its safety, how well the body handles it, and if it could help treat these conditions.
United States · Australia · Belgium